Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease.
作者信息
Triozzi Jefferson L, Richardson Peter A, Gregg L Parker, Navaneethan Sankar D
机构信息
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
VA Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, TX, USA.
出版信息
Nephrol Dial Transplant. 2021 Jul 23;36(8):1546-1548. doi: 10.1093/ndt/gfab046.
Abstract
摘要
相似文献
1
Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease.慢性肾病患者中非酒精性脂肪性肝病的发病率及预测因素
Nephrol Dial Transplant. 2021 Jul 23;36(8):1546-1548. doi: 10.1093/ndt/gfab046.
2
Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者慢性肾病的发病率
J Hepatol. 2020 Jul;73(1):214-216. doi: 10.1016/j.jhep.2020.03.003. Epub 2020 Mar 28.
3
Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease.非酒精性脂肪性肝病：慢性肾脏病的一个危险因素。
Ann Hepatol. 2023 Sep-Oct;28(5):101122. doi: 10.1016/j.aohep.2023.101122. Epub 2023 Jun 2.
4
Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?非酒精性脂肪性肝病与慢性肾脏病：肝脏硬度评估对肾脏有益？
Diabetes Metab. 2020 Sep;46(4):259-260. doi: 10.1016/j.diabet.2020.07.009. Epub 2020 Aug 1.
5
A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease.慢性肾脏病和非酒精性脂肪性肝病发病率上升的简要综述。
Physiol Int. 2019 Dec 1;106(4):305-310.
6
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect.非酒精性脂肪性肝病与慢性肾脏病：回顾、反思与展望
World J Gastroenterol. 2021 May 7;27(17):1864-1882. doi: 10.3748/wjg.v27.i17.1864.
7
Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood.非酒精性脂肪肝疾病与慢性肾脏病之间的关系可能从儿童期就开始了。
World J Gastroenterol. 2021 Sep 14;27(34):5793-5795. doi: 10.3748/wjg.v27.i34.5793.
8
Does diagnosing fatty liver and chronic kidney disease do more good than harm?诊断脂肪肝和慢性肾病是利大于弊吗？
PLoS Med. 2014 Jul 22;11(7):e1001681. doi: 10.1371/journal.pmed.1001681. eCollection 2014 Jul.
9
Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals.非酒精性脂肪肝与新发慢性肾脏病无关：基于组织学的大规模健康个体对照研究
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):441-3. doi: 10.1097/MEG.0000000000000531.
10
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现：最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
引用本文的文献
1
Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals.血清白蛋白与肌酐比值和非酒精性脂肪性肝病之间的关联：一项针对非肥胖中国人群的纵向队列研究。
BMC Gastroenterol. 2025 Aug 27;25(1):620. doi: 10.1186/s12876-025-04201-6.
2
Identification of key genes in membranous nephropathy and non-alcoholic fatty liver disease by bioinformatics and machine learning.通过生物信息学和机器学习鉴定膜性肾病和非酒精性脂肪性肝病中的关键基因
Front Immunol. 2025 Jun 5;16:1564288. doi: 10.3389/fimmu.2025.1564288. eCollection 2025.
3
From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease.从肝脏到肾脏：慢性肾脏病中非酒精性脂肪性肝病被忽视的负担
J Clin Med. 2025 Apr 5;14(7):2486. doi: 10.3390/jcm14072486.
4
Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort study.甘油三酯影响估算肾小球滤过率与非酒精性脂肪性肝病发病之间的关联：一项中国队列研究的二次分析
Front Med (Lausanne). 2022 Sep 27;9:984241. doi: 10.3389/fmed.2022.984241. eCollection 2022.
5
Evaluated Glomerular Filtration Rate Is Associated With Non-alcoholic Fatty Liver Disease: A 5-Year Longitudinal Cohort Study in Chinese Non-obese People.估算肾小球滤过率与非酒精性脂肪性肝病相关：一项针对中国非肥胖人群的5年纵向队列研究。
Front Nutr. 2022 Jun 16;9:916704. doi: 10.3389/fnut.2022.916704. eCollection 2022.
本文引用的文献
1
MAFLD and risk of CKD.MAFLD 和慢性肾脏病风险。
Metabolism. 2021 Feb;115:154433. doi: 10.1016/j.metabol.2020.154433. Epub 2020 Nov 16.
2
The association of low-grade albuminuria with incident non-alcoholic fatty liver disease and non-invasive markers of liver fibrosis by glycaemia status.根据血糖状态，低度白蛋白尿与新发非酒精性脂肪性肝病及肝纤维化非侵入性标志物之间的关联。
Liver Int. 2021 Jan;41(1):101-109. doi: 10.1111/liv.14649.
3
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义：国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
4
Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.非透析依赖型慢性肾脏病患者中绝对缺铁性贫血和功能性缺铁性贫血的患病率、相关因素和结局。
Nephrol Dial Transplant. 2021 Jan 1;36(1):129-136. doi: 10.1093/ndt/gfz192.
5
Epidemiology of chronic liver diseases in the USA in the past three decades.美国过去三十年慢性肝脏疾病的流行病学。
Gut. 2020 Mar;69(3):564-568. doi: 10.1136/gutjnl-2019-318813. Epub 2019 Jul 31.
6
Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.患有糖尿病肾病和非酒精性脂肪性肝病的患者发生心血管事件的风险增加。
Nephron. 2019;141(1):24-30. doi: 10.1159/000493472. Epub 2018 Nov 1.
7
Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.非酒精性脂肪性肝病与慢性肾脏病的临床转归。
Nephrol Dial Transplant. 2019 Mar 1;34(3):449-457. doi: 10.1093/ndt/gfx381.
8
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.非酒精性脂肪性肝病增加了慢性肾脏病发病的风险：系统评价和荟萃分析。
Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11.
9
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.非酒精性脂肪性肝病：慢性肾脏病的一个新的驱动因素。
Nat Rev Nephrol. 2017 May;13(5):297-310. doi: 10.1038/nrneph.2017.16. Epub 2017 Feb 20.
10
Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的新兴肝-肾相互作用。
Trends Mol Med. 2015 Oct;21(10):645-662. doi: 10.1016/j.molmed.2015.08.005.
Zotero 插件